In ovarian cancer patients, a positive correlation between LINC00092 and PFKFB2 protein expression was observed, which suggests that LINC00092 directly interacts with PFKFB2, maintains PFKFB2 enzyme stability, and modulates glycolysis during ovarian cancer progression and metastasis. This evidence concerns the gene PFKFB2 and ovarian cancer.